Guide
Heavy Metals Control for Dietary Supplements: USP <232>/<233>, ICP-MS Testing, Prop 65 Lead and Supplier Sourcing Discipline
Heavy metals — lead, arsenic, cadmium, mercury — are the most consequential contaminant class in dietary supplements. They occur naturally in botanicals (soil uptake), minerals (geological origin) and sea-derived ingredients (bioaccumulation), and they accumulate from a variety of industrial and agricultural sources. The USP framework (chapters <232> Elemental Impurities — Limits, <233> Elemental Impurities — Procedures, and <2232> for dietary supplements specifically) replaced the legacy USP <231> heavy metals colorimetric test with ICP-MS-based quantitative analysis and a Permitted Daily Exposure (PDE) framework. California Proposition 65 layers a separate, lower-threshold consumer-warning regime on top, with the 0.5 µg/day MADL for lead driving the most aggressive sourcing controls. This guide maps the regulatory and analytical regime and the operating posture that keeps heavy metals controlled.
Start free trial Free trial, no credit card, onboard in days, not months.
USP <232>, <233> and <2232> — the modern elemental impurities framework
USP <232> sets Permitted Daily Exposure (PDE) limits for the elemental impurities of concern, categorised by toxicity (Class 1: highest concern — As, Cd, Hg, Pb; Class 2A: route-dependent — Co, Ni, V; Class 2B and 3: lower concern with route-dependent limits). The PDE is a toxicology-derived daily intake limit; the in-product concentration limit is computed from the PDE divided by the maximum daily dose of the supplement. USP <2232> Elemental Contaminants in Dietary Supplements adapts the framework for supplements, with PDE values calibrated for oral supplement intake and the four-element default test panel (Pb, As, Cd, Hg). USP <233> Elemental Impurities — Procedures defines the analytical methodology: ICP-MS (Inductively Coupled Plasma Mass Spectrometry) as the primary technique, with ICP-OES (Optical Emission Spectroscopy) acceptable for elements at higher concentrations, and explicit validation requirements (specificity, accuracy, precision, range, ruggedness) per the validation approach of ICH Q2(R1).
ICP-MS in practice — sample prep, interferences and quantitation
ICP-MS measures elemental composition by ionising the sample in an argon plasma and quantifying the resulting ions by mass. Sample preparation is decisive: closed-vessel microwave digestion with concentrated nitric acid (and hydrogen peroxide or hydrochloric acid as needed) is the standard, fully digesting the matrix and releasing all elemental analytes. Open-vessel digestion is generally insufficient because volatile mercury can be lost. Interferences are mass-based — polyatomic ions can have the same mass as the analyte (40Ar35Cl on 75As is the classic) — and are handled by collision/reaction cell ICP-MS, by interference-equation correction, or by triple-quadrupole instruments (ICP-MS/MS) for the most demanding matrices. Quantitation uses internal standards (typically Sc, Ge, Rh, In, Bi to bracket the mass range), matrix-matched calibration curves, and the per-batch certified reference material to verify accuracy.
Prop 65 — the parallel lead regime that drives sourcing
California Proposition 65 layers a consumer-warning regime above USP. The MADL (Maximum Allowable Dose Level) for lead is 0.5 µg/day — far below the USP <2232> PDE for lead (5 µg/day for oral dietary supplements) — and this is the threshold that drives sourcing decisions for any product sold in California. A botanical at 0.5 ppm lead, dosed at 1 g/day, delivers 0.5 µg/day of lead — exactly at the MADL — and any modest variation puts the SKU over. The recurring litigation pattern: a citizen-suit plaintiff buys the product, sends it to an independent ICP-MS lab, computes per-daily-dose lead, serves Notice of Violation, settles. The defensible posture is per-lot ICP-MS heavy-metal testing with origin-segregated supplier records, per-batch finished-product testing for high-risk SKUs, and a computed per-daily-dose exposure analysis recorded against the batch.
Where the metal comes from — supplier sourcing and origin discipline
Heavy metal concentration in a finished supplement traces back to the ingredient supply chain. Botanical sourcing — soil mineralogy at the cultivation site, agricultural inputs (lead arsenate residues from historical orchard use, mercury from artisanal gold mining contamination of waterways), processing equipment (older grinding mills with leaded brass), and adulteration (lead chromate added to turmeric for colour) — all drive the input. Mineral ingredient sourcing — geological origin determines baseline (some calcium carbonate sources are intrinsically higher in lead, some magnesium sources higher in cadmium). Sea-derived ingredients (fish oil, krill, algae) accumulate mercury and cadmium proportional to trophic level and water-body history. Supplier qualification must cover origin disclosure, per-lot ICP-MS testing on the supplier side, an on-site audit programme for high-risk suppliers, and origin-change notification.
Operating posture — programme, certified reference materials and trending
Five-point heavy-metals posture. (1) USP <232>/<233>/<2232>-aligned spec per SKU, with the PDE and in-product limit derived from the daily dose. (2) Per-lot supplier COA verified by in-house or contract-lab ICP-MS retest on a defined frequency (every lot for high-risk botanicals, every Nth lot for qualified low-risk suppliers). (3) Per-batch finished-product ICP-MS for high-risk SKUs (botanicals, minerals, sea-derived, multi-ingredient blends). (4) Certified reference materials (NIST SRMs, commercial CRMs for botanical and food matrices) in every analytical run for accuracy verification. (5) Cross-lot and cross-supplier trending, with alert thresholds at, say, 50% of the spec limit so a sourcing drift triggers a review before the spec is breached.
Standards covered in this guide
Each standard, retailer code or assurance scheme referenced above has its own deep-dive page with scope, audit detail and common pitfalls.
Where this lives in V5 Ultimate
The clauses above aren't theoretical — every one maps to a shipped module and an industry profile. Jump to the parts of the product that turn this guide into evidence on a Monday morning.
Modules that do the work
Industries this hits hardest
Frequently asked
What USP chapter applies to heavy metals in supplements?
USP <2232> Elemental Contaminants in Dietary Supplements is the supplement-specific chapter, with Permitted Daily Exposure (PDE) values for lead, arsenic, cadmium and mercury calibrated for oral supplement intake. The general framework comes from USP <232> (limits) and USP <233> (procedures). The legacy USP <231> colorimetric heavy metals test was superseded by these chapters and is no longer the defensible method.
Why is Prop 65 lead so much lower than USP?
USP <2232> sets a PDE of 5 µg/day for lead in oral dietary supplements — a toxicology-derived limit calibrated for the supplement use case. California Proposition 65 sets a MADL of 0.5 µg/day for lead — derived as 1/1000 of the No Observable Effect Level for reproductive toxicity, the conservative public-health threshold of the right-to-know regime. A product can pass USP release and still trigger Prop 65 warning duty (or settlement-driven litigation) at typical daily doses for many botanicals.
Is ICP-OES acceptable instead of ICP-MS?
USP <233> permits ICP-OES (Optical Emission Spectroscopy) for elements present at higher concentrations where the method's detection limit is appropriate. For the four-element supplement default panel (Pb, As, Cd, Hg) at PDE-derived in-product limits, ICP-MS is the practical choice because the limits are typically in the low ppb range — below the ICP-OES quantitation limit for these elements in most supplement matrices.
How often should I test heavy metals?
Per-lot testing on every ingredient lot is the defensible baseline — supplier COA acceptance alone has been a recurring FDA Warning Letter finding. Per-batch finished-product testing is the bar for high-risk SKUs (botanicals, minerals, sea-derived, multi-ingredient blends sold into California). A skip-lot programme on qualified low-risk suppliers, with periodic verification, is acceptable for low-risk ingredients with established supplier history.
See it on your shop floor.
Free trial, no credit card, onboard in days, not months.
Related reading
- 10 CFR 35 medical use readiness — NRC licensing for radiopharmaceuticals
- 21 CFR 111 Readiness: Dietary Supplement cGMP Subparts E & F
- 21 CFR 211 Drug cGMP Readiness Guide
- 21 CFR 212 PET drug cGMP readiness — FDA inspection playbook
- 21 CFR 589 BSE / Ruminant Feed Ban Readiness Guide
- 21 CFR 820 to ISO 13485 Mapping Guide (Including QMSR Harmonisation)
Spot something off? .